JSI‐124 inhibits cell proliferation and tumor growth by inducing autophagy and apoptosis in murine malignant mesothelioma.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 12, p. 1888, doi. 10.1002/mc.23623
- By:
- Publication type:
- Article
Works matching IS 08991987 AND DT 2023 AND VI 62 AND IP 12
Results: 16
1
2
Tex10 interacts with STAT3 to regulate hepatocellular carcinoma growth and metastasis.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 12, p. 1974, doi. 10.1002/mc.23629
- By:
- Publication type:
- Article
3
Aberrant expression of CKS2 induced by ELK1 contributes to malignant progression of pancreatic cancer.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 12, p. 1947, doi. 10.1002/mc.23627
- By:
- Publication type:
- Article
4
Downregulation of cellular retinoic acid binding protein 1 fosters epithelial–mesenchymal transition in thyroid cancer.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 12, p. 1935, doi. 10.1002/mc.23626
- By:
- Publication type:
- Article
5
Loss of polarity protein Par3 in the intestinal epithelium promotes colitis‐associated colorectal cancer progression by damaging tight junction assembly.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 12, p. 1990, doi. 10.1002/mc.23630
- By:
- Publication type:
- Article
6
The action and resistance mechanisms of Lenvatinib in liver cancer.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 12, p. 1918, doi. 10.1002/mc.23625
- By:
- Publication type:
- Article
7
A novel m7G regulator‐based methylation patterns in head and neck squamous cell carcinoma.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 12, p. 1902, doi. 10.1002/mc.23624
- By:
- Publication type:
- Article
8
A systems biology approach and in vitro experiment indicated Rapamycin targets key cancer and cell cycle‐related genes and miRNAs in triple‐negative breast cancer cells.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 12, p. 1960, doi. 10.1002/mc.23628
- By:
- Publication type:
- Article
9
Protumorigenic role of the atypical cadherin FAT1 by the suppression of PDCD10 via RelA/miR221‐3p/222‐3p axis in glioblastoma.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 12, p. 1817, doi. 10.1002/mc.23617
- By:
- Publication type:
- Article
10
Integrated variant allele frequency analysis pipeline and R package: easyVAF.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 12, p. 1877, doi. 10.1002/mc.23621
- By:
- Publication type:
- Article
11
N6‐methyladenosine methylation regulatory pattern of pulmonary lymphoepithelioma‐like carcinoma based on exosomal transcriptome analysis.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 12, p. 1846, doi. 10.1002/mc.23619
- By:
- Publication type:
- Article
12
Integrated analysis of single cell and bulk RNA sequencing identifies CTHRC1<sup>+</sup>INHBA<sup>+</sup>CAF as drivers of colorectal cancer progression.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 12, p. 1787, doi. 10.1002/mc.23615
- By:
- Publication type:
- Article
13
Identification and validation of DNA methylation‐driven gene PCDHB4 as a novel tumor suppressor for glioblastoma diagnosis and prognosis.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 12, p. 1832, doi. 10.1002/mc.23618
- By:
- Publication type:
- Article
14
A novel hypoxia‐stimulated lncRNA HIF1A‐AS3 binds with YBX1 to promote ovarian cancer tumorigenesis by suppressing p21 and AJAP1 transcription.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 12, p. 1860, doi. 10.1002/mc.23620
- By:
- Publication type:
- Article
15
Regulation of SELENOF translation by eIF4a3: Possible role in prostate cancer progression.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 12, p. 1803, doi. 10.1002/mc.23616
- By:
- Publication type:
- Article
16
Issue Information ‐ Ed Board.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 12, p. 1783, doi. 10.1002/mc.23434
- Publication type:
- Article